These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37353384)

  • 21. LncRNA DANCR promotes ATG7 expression to accelerate hepatocellular carcinoma cell proliferation and autophagy by sponging miR-222-3p.
    Wang X; Cheng ML; Gong Y; Ma WJ; Li B; Jiang YZ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8778-8787. PubMed ID: 32964966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
    Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
    Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction notice to "Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma" [Biomed. Pharmacother., 98 (2018) 899 - 906].
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2024 Feb; 171():116197. PubMed ID: 38296733
    [No Abstract]   [Full Text] [Related]  

  • 24. Retraction notice to "MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1" [Biomed. Pharmacother. 102 (2018) 988-995].
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2023 Aug; 164():114723. PubMed ID: 37088668
    [No Abstract]   [Full Text] [Related]  

  • 25. Crosstalk between lncRNA DANCR and miR-125b-5p in HCC cell progression.
    Yang L; Jiang MN; Liu Y; Wu CQ; Liu H
    Tumori; 2021 Dec; 107(6):504-513. PubMed ID: 33272103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis.
    Zheng Y; Zheng B; Meng X; Yan Y; He J; Liu Y
    Cancer Cell Int; 2019; 19():302. PubMed ID: 31827393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-214-5p targeted by LncRNA DANCR mediates TGF-β signaling pathway to accelerate proliferation, migration and inhibit apoptosis of prostate cancer cells.
    Deng H; Zhu B; Dong Z; Jiang H; Zhao X; Wu S
    Am J Transl Res; 2021; 13(4):2224-2240. PubMed ID: 34017385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a.
    Zhen Q; Gao LN; Wang RF; Chu WW; Zhang YX; Zhao XJ; Lv BL; Liu JB
    Cancer Control; 2018; 25(1):1073274818769849. PubMed ID: 29651883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2023 Nov; 167():115375. PubMed ID: 37802728
    [No Abstract]   [Full Text] [Related]  

  • 30. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1.
    Wu Z; Liu Y; Wei L; Han M
    J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p.
    Liang H; Zhang C; Guan H; Liu J; Cui Y
    J Cell Physiol; 2019 May; 234(5):7266-7278. PubMed ID: 30362591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of circular RNA hsa_circ_0007534 suppresses cell growth by regulating miR-219a-5p/SOX5 axis in osteosarcoma.
    Zhang P; Li J
    J Bone Oncol; 2021 Apr; 27():100349. PubMed ID: 33552887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction notice to "miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells" [Biomed. Pharmacother. 95 (2017) 120-128].
    Cai W; Jiang H; Yu Y; Xu Y; Zuo W; Wang S; Su Z
    Biomed Pharmacother; 2023 Apr; 160():114282. PubMed ID: 36725469
    [No Abstract]   [Full Text] [Related]  

  • 34. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 35. The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway.
    Zhang R; Hao Y; Zhang J
    Cell Mol Biol Lett; 2022 Feb; 27(1):15. PubMed ID: 35177003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway.
    Wang W; Li Y; Ma Q; Yan H; Su W
    Onco Targets Ther; 2019; 12():2439-2449. PubMed ID: 31114219
    [No Abstract]   [Full Text] [Related]  

  • 37. Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2022 Jan; 145():112511. PubMed ID: 34895810
    [No Abstract]   [Full Text] [Related]  

  • 38. LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis.
    Shi H; Li K; Feng J; Liu G; Feng Y; Zhang X
    Front Oncol; 2020; 10():1034. PubMed ID: 32766131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis.
    Lu W; Huang Z; Wang J; Liu H
    J Biochem; 2022 Mar; 171(4):389-398. PubMed ID: 33481014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].
    Liu X; Li Y; Wen J; Qi T; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113356. PubMed ID: 35835667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.